Monograph on the Potential Human Reproductive and ... - OEHHA
Monograph on the Potential Human Reproductive and ... - OEHHA
Monograph on the Potential Human Reproductive and ... - OEHHA
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
BISPHENOL A<br />
Table 7<br />
Blood C<strong>on</strong>centrati<strong>on</strong>s of Bisphenol A in Adults<br />
Populati<strong>on</strong> (n) Bisphenol A mg/L a,c<br />
Method Reference<br />
Germany<br />
Men (7) o0.5 HPLC-MS/MS Völkel et al. (2005)<br />
Women (12) o0.5 HPLC-MS/MS Völkel et al. (2005)<br />
Pregnant Caucasian women (37; 32–41 4.473.9 GC-MS Schönfelder et al. (2002a)<br />
weeks gestati<strong>on</strong>)<br />
Japan<br />
Men (21; age 22–51) ‘‘almost all’’ o0.2 ng/ml HPLC-ECD Fukata et al. (2006)<br />
Men (9; age 30–50) 0.5970.21 (0.38–1.0) HPLC-MS Sajiki et al.(1999)<br />
Men (11) 1.4970.11 (SEM) ELISA b<br />
Takeuchi <strong>and</strong> Tsutsumi<br />
(2002)<br />
Women (31; age 22–51) ‘‘almost all’’ o0.2 ng/ml HPLC-ECD Fukata et al. (2006)<br />
Women (12; age 30–50) 0.3370.54 (0–1.6) HPLC-MS Sajiki et al.(1999)<br />
Women (14) 0.6470.10(SEM) ELISA b<br />
Takeuchi <strong>and</strong> Tsutsumi<br />
Pregnant women (37; late pregnancy) 1.470.9 ELISA<br />
(2002)<br />
b<br />
Ikezuki et al.(2002)<br />
Pregnant women with normal karyotype 2.24 (0.63–14.36) ELISA b<br />
early 2nd trimester (200)<br />
Yamada et al. (2002)<br />
Pregnant women with abnormal 2.97 (B0.0.7–18.5) d<br />
ELISA b<br />
karyotype early 2nd trimester (48)<br />
Yamada et al. (2002)<br />
Pregnant women (9) 0.43 (0.21–0.79) HPLC-Fl Kuroda et al. (2003)<br />
Infertile women (21) 0.46 (0.22–0.87) HPLC-Fl Kuroda et al. (2003)<br />
Women with multiple miscarriages 2.5975.23 ELISA b<br />
Sugiura-Ogasawara et al.<br />
(45; mean age 31.6 years) (2005)<br />
Healthy woman (32; mean age 32 years) 0.7770.38 ELISA b<br />
Sugiura-Ogasawara et al.<br />
(2005)<br />
Women with polycystic ovary syndrome 1.0470.10 (SEM) ELISA b<br />
Takeuchi <strong>and</strong> Tsutsumi<br />
(16) (2002)<br />
N<strong>on</strong>-obese women with polycystic 1.0570.10 (SEM) ELISA b<br />
ovarian syndrome (13; average<br />
age 26.5 years)<br />
Takeuchi et al. (2004a)<br />
Obese women with polycystic ovarian 1.1770.16 (SEM) ELISA b<br />
syndrome (6; average age 24.7 years)<br />
Takeuchi et al. (2004a)<br />
N<strong>on</strong>-obese women (19; average age 27.5 0.7170.09 (SEM) ELISA b<br />
Takeuchi <strong>and</strong> Tsutsumi<br />
years) (2002)<br />
Obese women (7; average age 28.8 years) 1.0470.09 (SEM) ELISA b<br />
Takeuchi et al. (2004a)<br />
Hyperprolactinemic women (7; average 0.8370.12 (SEM) ELISA b<br />
age 27.7 years)<br />
Takeuchi et al. (2004a)<br />
Amenorrheic women (7; average age 0.8470.10 (SEM) ELISA b<br />
25.1 years)<br />
Takeuchi et al. (2004a)<br />
Women with normal uterine 2.571.5 ELISA b<br />
endometrium (11; mean age 48.9 years<br />
Hiroi et al. (2004)<br />
Women with simple endometrium 2.972.0 ELISA b<br />
hyperplasia (10; mean age 48.4 years)<br />
Hiroi et al. (2004)<br />
Women with complex endometrium 1.470.4 ELISA b<br />
hyperplasia (9; mean age 48.4 years)<br />
Hiroi et al. (2004)<br />
Women with endometrial carcinoma 1.470.5 ELISA b<br />
(7; mean age 63.1 years)<br />
Hiroi et al. (2004)<br />
a<br />
Mean7SD or median (range).<br />
b<br />
As discussed in Secti<strong>on</strong> 1.1.5, ELISA may overestimate bisphenol A.<br />
c<br />
It is uncertain whe<strong>the</strong>r parent, c<strong>on</strong>jugated, or total bisphenol A was measured.<br />
d<br />
Estimated from a graph.<br />
Schönfelder et al. (2002b) examined bisphenol A<br />
c<strong>on</strong>centrati<strong>on</strong>s in maternal <strong>and</strong> fetal blood <strong>and</strong> compared<br />
bisphenol A c<strong>on</strong>centrati<strong>on</strong>s in blood of male <strong>and</strong> female<br />
fetuses. In a study c<strong>on</strong>ducted at a German medical<br />
center, blood samples were obtained from 37 Caucasian<br />
women between 32 <strong>and</strong> 41 weeks gestati<strong>on</strong>. At parturiti<strong>on</strong>,<br />
blood was collected from <strong>the</strong> umbilical vein after<br />
expulsi<strong>on</strong> of <strong>the</strong> placenta. Bisphenol A c<strong>on</strong>centrati<strong>on</strong>s in<br />
plasma were measured by GC/MS. C<strong>on</strong>trol experiments<br />
were c<strong>on</strong>ducted to verify that bisphenol A did not leach<br />
Birth Defects Research (Part B) 83:157–395, 2008<br />
169<br />
from collecti<strong>on</strong>, storage, or testing equipment. Bisphenol<br />
A was detected in all samples tested, <strong>and</strong> c<strong>on</strong>centrati<strong>on</strong>s<br />
measured in maternal <strong>and</strong> fetal blood are summarized in<br />
Table 9. Mean bisphenol A c<strong>on</strong>centrati<strong>on</strong>s were higher in<br />
maternal (4.473.9 [SD] mg/L) than fetal blood<br />
(2.972.5 mg/L). Study authors noted that in 14 cases<br />
fetal bisphenol A plasma c<strong>on</strong>centrati<strong>on</strong>s exceeded those<br />
detected in maternal plasma. Am<strong>on</strong>g those 14 cases, 12<br />
fetuses were male. Analysis by paired t-test revealed<br />
significantly higher mean bisphenol A c<strong>on</strong>centrati<strong>on</strong>s in